Daniel R Kaul
Clinical Professor of Internal Medicine
Program Director, Fellowship - Infectious Diseases, Medical School
Email:
[email protected]
Available to mentor
Daniel R Kaul
Clinical Professor
Manage Your Profile
Recent Publications
-
Ison MG, Blumberg E, Green M, Kaul D, Wolfe CR, Michaels MG, La Hoz RM, Danziger-Isakov L. Am J Transplant, 2026 Oct 16;Journal ArticleTransparency and Continuity in Organ Safety and Vigilance: Concerns Regarding the Transition from DTAC to TRACE.
DOI:10.1016/j.ajt.2026.10.011 PMID: 42887873 -
Boutin CA, Callegari M, Florescu D, Nguyen MH, Kaul D, Avery R, Chong P, Fisher C, Limaye AP, Clough L, Pergam SA, Green M, Michaels MG, Danziger-Isakov LA, Angarone M, Keefer L, Daud A, Lorenzo-Redondo R, Tan M, Ison MG. American Journal of Transplantation, 2026 Sep 1; 26 (9): 2169 - 2181.Journal ArticleA phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipients
DOI:10.1016/j.ajt.2026.04.010 PMID: 42177030 -
Schildknecht KR, Williams PM, Schwartz NG, Haddad MB, Stewart RJ, Annambhotla P, Basavaraju SV, Nabity SA, Keh CE, Calvet HM, Zahn MM, Beltrán R, Cortez A, Lomeli A, Percak JM, Goozé LL, Coloma M, Shaw T, Davidson PJ, Smith SR, Dickson RP, Kaul DR, Gonzalez AR, Rodriguez G, Decimo A, Sanchez A, Armitige LY, Stapleton J, Lacassagne M, Brown C, Zheng C, Ali J, Wolfe AW, Young LR, Ariail K, Behm H, Jordan HT, Spencer M, Nilsen DM, Goradia R, Denison BM, Burgos M, Leonard JM, Cortes E, Thacker TC, Lehman KA, Villalba JA, Bhatnagar J, Reagan-Steiner S, Althomsons SP, Goswami ND, Cowan LS, Starks AM, Wortham JM, LoBue PA, Investigators TBAT. 2026 May 8; medRxiv,PreprintSecond multistate outbreak of tuberculosis caused by a bone allograft product
DOI:10.64898/2026.04.29.26351868 -
Goepfert P, Katz MJ, Kaul D, Sharma T, Kaur D, Falck-Ytter Y, Baden L. Clinical Infectious Diseases, 2026 Apr 15; 82: i117 - i122.Journal ArticleIDSA 2025 Guideline on the Use of Vaccines for the Prevention of Seasonal Influenza Infections in Immunocompromised Patients
DOI:10.1093/cid/ciag116 PMID: 41762115 -
Nellore A, Goepfert P, Tan CS, Bajema K, Belden K, Blumberg D, Katz MJ, Kaul D, Sharma T, Anjan S, Ariza-Heredia EJ, Magana F, Minniear T, Loveless J, Kaur D, York E, Falck-Ytter Y, Baden L. Clinical Infectious Diseases, 2026 Apr 15; 82: i105 - i110.Journal ArticleIDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients
DOI:10.1093/cid/ciag114 PMID: 41766454 -
Zimmerman MS, Hixson H, Walter K, Chan K, Kaul D, Combs M. The Journal of Heart and Lung Transplantation, 2026 May 6; 45 (5): 679 - 679.Proceeding / Abstract / Poster(1474) Incidence of Herpes Zoster Virus Infection in Lung Transplant Recipients on Long-Term HZV Prophylaxis
DOI:10.1016/j.healun.2026.02.1488 -
Raglow Z, Kaul D, Rodriguez AM, Oliveira Gonçalves AS, Henry-Szatkowski M, Ginchereau Sowell F, Bullano M, Gelone DK, Schultz BG. Current Medical Research and Opinion, 2026 Jan 1; 42 (3): 529 - 539.Journal ArticleQuantifying US healthcare provider preferences for the treatment of post-transplant cytomegalovirus infection using a discrete choice experiment
DOI:10.1080/03007995.2026.2676335 PMID: 42208040 -
Taber D, Raglow Z, Kaul D, Rodriguez A, Henry-Szatkowski M, Sowell FG, Bullano M, Schultz BG, Gelone DK. American Journal of Transplantation, 2025 Aug 4; 25 (8): s589Journal ArticleHealthcare Provider (HCP) Preferences for Treatment of Post-Transplant Cytomegalovirus Infection (CMVi)
DOI:10.1016/j.ajt.2025.07.1377